<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kavanagh DG</submitter><funding>NIAID NIH HHS</funding><pagination>1963-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1895708</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>107(5)</volume><pubmed_abstract>Transfection with synthetic mRNA is a safe and efficient method of delivering antigens to dendritic cells for immunotherapy. Targeting antigens to the lysosome can sometimes enhance the CD4+ T-cell response. We transfected antigen-presenting cells (APCs) with mRNA encoding Gag-p24 and cytoplasmic, lysosomal, and secreted forms of Nef. Antigen-specific cytotoxic T cells were able to lyse the majority of transfected targets, indicating that transfection was efficient. Transfection of APCs with a Nef construct bearing lysosomal targeting signals produced rapid and prolonged antigen presentation to CD4+ and CD8+ T cells. Polyclonal CD4+ and CD8+ T-cell lines recognizing multiple distinct epitopes were expanded by coculture of transfected dendritic cells with peripheral blood mononuclear cells from viremic and aviremic HIV-infected subjects. Importantly, lysosome-targeted antigen drove a significantly greater expansion of Nef-specific CD4+ T cells than cytoplasmic antigen. The frequency of recognition of CD8 but not CD4 epitopes by mRNA-expanded T cells was inversely proportional to sequence entropy and was similar to ex vivo responses from a large chronic cohort. Thus human dendritic cells transfected with mRNA encoding lysosome-targeted HIV antigen can expand a broad, polyclonal repertoire of antiviral T cells, offering a promising approach to HIV immunotherapy.</pubmed_abstract><journal>Blood</journal><pubmed_title>Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.</pubmed_title><pmcid>PMC1895708</pmcid><funding_grant_id>1 F32 AI058457-01</funding_grant_id><funding_grant_id>N01-AI-15422</funding_grant_id><funding_grant_id>F32 AI058457</funding_grant_id><pubmed_authors>Walker BD</pubmed_authors><pubmed_authors>Boczkowski D</pubmed_authors><pubmed_authors>Kaufmann DE</pubmed_authors><pubmed_authors>Gilboa E</pubmed_authors><pubmed_authors>Frahm N</pubmed_authors><pubmed_authors>Kavanagh DG</pubmed_authors><pubmed_authors>Sunderji S</pubmed_authors><pubmed_authors>Bhardwaj N</pubmed_authors><pubmed_authors>Stone DR</pubmed_authors><pubmed_authors>Le Gall S</pubmed_authors><pubmed_authors>Rosenberg ES</pubmed_authors><pubmed_authors>Johnston MN</pubmed_authors><pubmed_authors>Zaman MT</pubmed_authors><pubmed_authors>Brander C</pubmed_authors><pubmed_authors>Wagner BS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.</name><description>Transfection with synthetic mRNA is a safe and efficient method of delivering antigens to dendritic cells for immunotherapy. Targeting antigens to the lysosome can sometimes enhance the CD4+ T-cell response. We transfected antigen-presenting cells (APCs) with mRNA encoding Gag-p24 and cytoplasmic, lysosomal, and secreted forms of Nef. Antigen-specific cytotoxic T cells were able to lyse the majority of transfected targets, indicating that transfection was efficient. Transfection of APCs with a Nef construct bearing lysosomal targeting signals produced rapid and prolonged antigen presentation to CD4+ and CD8+ T cells. Polyclonal CD4+ and CD8+ T-cell lines recognizing multiple distinct epitopes were expanded by coculture of transfected dendritic cells with peripheral blood mononuclear cells from viremic and aviremic HIV-infected subjects. Importantly, lysosome-targeted antigen drove a significantly greater expansion of Nef-specific CD4+ T cells than cytoplasmic antigen. The frequency of recognition of CD8 but not CD4 epitopes by mRNA-expanded T cells was inversely proportional to sequence entropy and was similar to ex vivo responses from a large chronic cohort. Thus human dendritic cells transfected with mRNA encoding lysosome-targeted HIV antigen can expand a broad, polyclonal repertoire of antiviral T cells, offering a promising approach to HIV immunotherapy.</description><dates><release>2006-01-01T00:00:00Z</release><publication>2006 Mar</publication><modification>2020-11-19T13:47:35Z</modification><creation>2019-03-27T02:04:11Z</creation></dates><accession>S-EPMC1895708</accession><cross_references><pubmed>16249391</pubmed><doi>10.1182/blood-2005-04-1513</doi></cross_references></HashMap>